id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0379-0007,FDA,FDA-2011-E-0379,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T13:27:04Z,,0,0,090000648119d57e
FDA-2011-E-0379-0006,FDA,FDA-2011-E-0379,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2012-04-09T04:00:00Z,2012,4,2012-04-09T04:00:00Z,,2012-04-09T12:38:05Z,,0,0,0900006480feb75d
FDA-2011-E-0379-0005,FDA,FDA-2011-E-0379,Determination of Regulatory Review Periods for Posposes pf Patent Extension: NATROBA,Notice,General Notice,2012-04-06T04:00:00Z,2012,4,2012-04-06T04:00:00Z,2012-05-06T03:59:59Z,2014-02-28T18:26:02Z,2012-08337,0,0,0900006480feab8f
FDA-2011-E-0379-0004,FDA,FDA-2011-E-0379,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-03-12T04:00:00Z,2012,3,2012-03-12T04:00:00Z,,2012-03-13T11:59:52Z,,0,0,0900006480fd3b30
FDA-2011-E-0379-0003,FDA,FDA-2011-E-0379,FDA\CDER to United States Patent and Trademark Office - Letter,Other,Letter(s),2011-06-23T04:00:00Z,2011,6,2011-06-23T04:00:00Z,,2011-06-23T15:48:41Z,,0,0,0900006480e9f17d
FDA-2011-E-0379-0001,FDA,FDA-2011-E-0379,"Eli Lilly and Co. (Barnes & Thornburg, LLP) - Patent Extension Application",Other,APP-Application,2011-05-18T04:00:00Z,2011,5,2011-05-18T04:00:00Z,,2013-08-11T04:45:53Z,,0,0,0900006480d4da61
FDA-2011-E-0379-0002,FDA,FDA-2011-E-0379,U.S. Patent & Trademark Office - Letter,Other,LET-Letter,2011-05-18T04:00:00Z,2011,5,2011-05-18T04:00:00Z,,2011-05-18T20:49:56Z,,0,0,0900006480d4da63